Review
Open access
Sep 2026
Promises and Pitfalls of ctDNA testing in the Management of Cholangiocarcinoma.
Diagnosis and treatment of cholangiocarcinoma is often limited by the availability of tissue biopsies for genomic analysis. Liquid biopsies using blood circulating tumor DNA (ctDNA) have emerged as a valuable and non-invasive alternative to conventional testing. ctDNA analysis has advanced the treatment paradigm for ch...
Min-Gen Liu, B. Doger, A. Pant et al.
· JHEP Reports · 0 citations